Biofluid Research on Age-Related or Inherited Neurodegeneration
Public ClinicalTrials.gov record NCT07798700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biofluid Research on Age-Related or Inherited Neurodegeneration (BRAIN)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to contribute to and continue to sustain a repository of blood samples, nucleic acid (DNA and/or RNA) samples, family history information, and other demographic information from individuals with age-related neurodegenerative conditions, or their family members who may or may not be at risk for similar conditions. This study will continue to further expand research into the molecular and genetic basis of these diseases and their risk factors.
Study identification
- NCT ID
- NCT07798700
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
- Frontotemporal Degeneration (FTD)
- ALS (Amyotrophic Lateral Sclerosis)
- Primary Progressive Aphasia (PPA)
- Familial Frontotemporal Lobar Degeneration (fFTLD)
- Fronto-temporal Lobar Dementia
- Dementia With Lewy Bodies (DLB)
- Cortical Basal Syndrome (CBS)
- Alzheimer's Disease (AD)
- Progressive Supranuclear Palsy(PSP)
- Parkinson's Disease (PD)
- Parkinson's Disease Dementia (PDD)
- Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)
- Posterior Cortical Atrophy (PCA)
- Primary Lateral Sclerosis (PLS)
- Primary Muscular Atrophy (PMA)
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2025 (Actual)
- Primary completion
- Jan 1, 2070 (Estimated)
- Completion
- Jan 1, 2070 (Estimated)
- Last update posted
- Sep 1, 2026
2025 – 2070
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07798700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07798700 live on ClinicalTrials.gov.